Citations (44)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Ludger Sellmann, Alexander Carpinteiro, Holger Nückel, René Scholtysik, Dörte Siemer, Ludger Klein-Hipass, Dieter Kube, Jan Dürig, Ulrich Dührsen, Jens Stanelle & Ralf Küppers. (2012) p53 protein expression in chronic lymphocytic leukemia. Leukemia & Lymphoma 53:7, pages 1282-1288.
Read now
Read now
Marie Sevov, Richard Rosenquist & Larry Mansouri. (2012) RNA-based markers as prognostic factors in chronic lymphocytic leukemia. Expert Review of Hematology 5:1, pages 69-79.
Read now
Read now
Tait D. Shanafelt, Kari G. Rabe, Neil E. Kay, Clive S. Zent, Timothy G. Call, Susan L. Slager, Deborah A. Bowen, Susan M. Schwager & Grzegorz S. Nowakowski. (2010) Statin and non-steroidal anti-inflammatory drug use in relation to clinical outcome among patients with Rai stage 0 chronic lymphocytic leukemia. Leukemia & Lymphoma 51:7, pages 1233-1240.
Read now
Read now
Monica Lopez-Guerra & Dolors Colomer. (2010) NF-κB as a therapeutic target in chronic lymphocytic leukemia. Expert Opinion on Therapeutic Targets 14:3, pages 275-288.
Read now
Read now
Eloisa Jantus Lewintre, Cristina Reinoso Martín, David Montaner, Miguel Marín, María José Terol, Rosa Farrás, Isabel Benet, Juan J. Calvete, Joaquín Dopazo & Javier García-Conde. (2009) Analysis of chronic lymphotic leukemia transcriptomic profile: differences between molecular subgroups. Leukemia & Lymphoma 50:1, pages 68-79.
Read now
Read now
Tom Butler & John G Gribben. (2008) Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients. Expert Opinion on Medical Diagnostics 2:1, pages 101-112.
Read now
Read now
E. A. Nikitin, S. G. Malakho, B. V. Biderman, A. V. Baranova, Y. Y. Lorie, A. Y. Shevelev, M. M. Peklo, T. N. Vlasik, E. A. Moskalev, B. V. Zingerman, I. A. Vorob'ev, A. B. Poltaraus, A. B. Sudarikov & A. I. Vorobjev. (2007) Expression level of lipoprotein lipase and dystrophin genes predict survival in B-cell chronic lymphocytic leukemia. Leukemia & Lymphoma 48:5, pages 912-922.
Read now
Read now
Articles from other publishers (37)
Haidong Li, Heejeong Kim, Jingjing Han, Van‐Nghia Nguyen, Xiaojun Peng & Juyoung Yoon. (2021) Activity‐based smart AIEgens for detection, bioimaging, and therapeutics: Recent progress and outlook. Aggregate 2:4.
Crossref
Crossref
Nina Kreuzberger, Johanna AAG Damen, Marialena Trivella, Lise J Estcourt, Angela Aldin, Lisa Umlauff, Maria DLA Vazquez-Montes, Robert Wolff, Karel GM Moons, Ina Monsef, Farid Foroutan, Karl-Anton Kreuzer & Nicole Skoetz. (2020) Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis. Cochrane Database of Systematic Reviews 2020:7.
Crossref
Crossref
Christian Schmidl, Gregory I. Vladimer, André F. Rendeiro, Susanne Schnabl, Thomas Krausgruber, Christina Taubert, Nikolaus Krall, Tea Pemovska, Mohammad Araghi, Berend Snijder, Rainer Hubmann, Anna Ringler, Kathrin Runggatscher, Dita Demirtas, Oscar Lopez de la Fuente, Martin Hilgarth, Cathrin Skrabs, Edit Porpaczy, Michaela Gruber, Gregor Hoermann, Stefan Kubicek, Philipp B. Staber, Medhat Shehata, Giulio Superti-Furga, Ulrich Jäger & Christoph Bock. (2019) Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL. Nature Chemical Biology 15:3, pages 232-240.
Crossref
Crossref
Daniel Prieto & Pablo Oppezzo. (2017) Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia: New Insights into Leukemic Progression. Molecules 22:12, pages 2083.
Crossref
Crossref
Teodora Karan‐Djurasevic & Sonja Pavlovic. 2017. Lymphocyte Updates - Cancer, Autoimmunity and Infection. Lymphocyte Updates - Cancer, Autoimmunity and Infection.
Irfan Yavasoglu, Gokhan Sargin, Fergun Yilmaz, Sermin Altındag, Gulsum Akgun, Anil Tombak, Bila Toka, Sinan Dal, Hasan Ozbas, Guven Cetin, Ayhan Donmez, Zeynep Arzu Yegin, Oktay Bilgir, Naci Tiftik, Sehmus Ertop, Orhan Ayyildiz, Mehmet Sonmez, Gokhan Pektas, Gurhan Kadıkoylu, Murat Tombuloglu & Zahit Bolaman. (2017) Cholesterol Levels in Patients with Chronic Lymphocytic Leukemia. Journal of the National Medical Association 109:1, pages 23-27.
Crossref
Crossref
Zoltán Mátrai, Hajnalka Andrikovics, Anikó Szilvási, András Bors, András Kozma, Emma Ádám, Gabriella Halm, Éva Karászi, Attila Tordai & Tamás Masszi. (2016) Lipoprotein Lipase as a Prognostic Marker in Chronic Lymphocytic Leukemia. Pathology & Oncology Research 23:1, pages 165-171.
Crossref
Crossref
Juan Luis Fernández-Martínez, Enrique J. deAndrés-Galiana & Stephen T. Sonis. (2017) Genomic data integration in chronic lymphocytic leukemia. The Journal of Gene Medicine 19:1-2, pages e2936.
Crossref
Crossref
Enrique J. deAndrés-Galiana, Juan L. Fernández-Martínez & Stephen T. Sonis. (2016) Sensitivity analysis of gene ranking methods in phenotype prediction. Journal of Biomedical Informatics 64, pages 255-264.
Crossref
Crossref
Ans Rombout, Bruno Verhasselt & Jan Philippé. (2016) Lipoprotein lipase in chronic lymphocytic leukemia: function and prognostic implications. European Journal of Haematology 97:5, pages 409-415.
Crossref
Crossref
P-P Liu, J Liu, W-Q Jiang, J S Carew, M A Ogasawara, H Pelicano, C M Croce, Z Estrov, R-H Xu, M J Keating & P Huang. (2016) Elimination of chronic lymphocytic leukemia cells in stromal microenvironment by targeting CPT with an antiangina drug perhexiline. Oncogene 35:43, pages 5663-5673.
Crossref
Crossref
William B. Kinlaw, Paul W. Baures, Leslie E. Lupien, Wilson L. Davis & Nancy B. Kuemmerle. (2016) Fatty Acids and Breast Cancer: Make Them on Site or Have Them Delivered. Journal of Cellular Physiology 231:10, pages 2128-2141.
Crossref
Crossref
Louise Kristensen, Thomas Kristensen, Niels Abildgaard, Cristina Royo, Mikael Frederiksen, Torben Mourits-Andersen, Elias Campo & Michael Boe M?ller. (2016)
LPL
gene expression is associated with poor prognosis in CLL and closely related to
NOTCH1
mutations
. European Journal of Haematology 97:2, pages 175-182.
Crossref
Crossref
Yi Que, Feng Jiang, Liting Liu, Yuanfang Li, Yongming Chen, Haibo Qiu, Zhiwei Zhou & Xing Zhang. (2015) Clinical Significance of Preoperative Serum High Density Lipoprotein Cholesterol Levels in Soft Tissue Sarcoma. Medicine 94:18, pages e844.
Crossref
Crossref
Shen-Miao Yang, Jian-Yong Li, Robert Peter Gale & Xiao-Jun Huang. (2015) The mystery of chronic lymphocytic leukemia (CLL): Why is it absent in Asians and what does this tell us about etiology, pathogenesis and biology?. Blood Reviews 29:3, pages 205-213.
Crossref
Crossref
Maria Göbel, Lewin Eisele, Michael Möllmann, Andreas Hüttmann, Patricia Johansson, René Scholtysik, Manuela Bergmann, Raymonde Busch, Hartmut Döhner, Michael Hallek, Till Seiler, Stephan Stilgenbauer, Ludger Klein-Hitpass, Ulrich Dührsen & Jan Dürig. (2013) Progranulin Is a Novel Independent Predictor of Disease Progression and Overall Survival in Chronic Lymphocytic Leukemia. PLoS ONE 8:8, pages e72107.
Crossref
Crossref
Edit Porpaczy, Stefanie Tauber, Martin Bilban, Gerhard Kostner, Michaela Gruber, Sandra Eder, Daniel Heintel, Trang Le, Karin Fleiss, Cathrin Skrabs, Medhat Shehata, Ulrich J?ger & Katrina Vanura. (2013) Lipoprotein lipase in chronic lymphocytic leukaemia ? Strong biomarker with lack of functional significance. Leukemia Research 37:6, pages 631-636.
Crossref
Crossref
Teodora Karan-Djurasevic, Vuk Palibrk, Branka Zukic, Vesna Spasovski, Irena Glumac, Milica Colovic, Natasa Colovic, Vladimir Jurisic, Andreas Scorilas, Sonja Pavlovic & Natasa Tosic. (2013) Expression of Bcl2L12 in chronic lymphocytic leukemia patients: association with clinical and molecular prognostic markers. Medical Oncology 30:1.
Crossref
Crossref
Shih-Shih ChenRainer ClausDavid M. LucasLianbo Yu, Jiang QianAmy S. Ruppert, Derek A. WestKatie E. WilliamsAmy J. JohnsonFred Sablitzky, Christoph PlassJohn C. Byrd. (2011) Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood 117:3, pages 862-871.
Crossref
Crossref
Ludger Sellmann, Rene Scholtysik, Markus Kreuz, Sandra Cyrull, Enrico Tiacci, Jens Stanelle, Alexander Carpinteiro, Holger N?ckel, Tanja Boes, Stefan Gesk, Reiner Siebert, Ludger Klein-Hitpass, Ulrich D?hrsen, Jan D?rig & Ralf K?ppers. (2010) Gene dosage effects in chronic lymphocytic leukemia. Cancer Genetics and Cytogenetics 203:2, pages 149-160.
Crossref
Crossref
Sonja Katharina K?nigs, Christian Philipp Pallasch, Lars Hartwin Lindner, Janine Schwamb, Alexandra Schulz, Reinhild Brinker, Julia Claasen, Aditya Veldurthy, Hansjoerg Eibl, Michael Hallek & Clemens-Martin Wendtner. (2010) Erufosine, a novel alkylphosphocholine, induces apoptosis in CLL through a caspase-dependent pathway. Leukemia Research 34:8, pages 1064-1069.
Crossref
Crossref
Jana Kotaskova, Boris Tichy, Martin Trbusek, Hana Skuhrova Francova, Jitka Kabathova, Jitka Malcikova, Michael Doubek, Yvona Brychtova, Jiri Mayer & Sarka Pospisilova. (2010) High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated Immunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival. The Journal of Molecular Diagnostics 12:3, pages 328-334.
Crossref
Crossref
Tom Butler & J.G. Gribben. (2010) Biologic and clinical significance of molecular profiling in Chronic Lymphocytic Leukemia. Blood Reviews 24:3, pages 135-141.
Crossref
Crossref
John G. Gribben. (2010) How I treat CLL up front. Blood 115:2, pages 187-197.
Crossref
Crossref
Holger N?ckel, Crista H. Collins, Ulrich H. Frey, Ludger Sellmann, Jan D?rig, Winfried Siffert & Ulrich D?hrsen. (2009) FCRL2 mRNA expression is inversely associated with clinical progression in chronic lymphocytic leukemia. European Journal of Haematology 83:6, pages 541-549.
Crossref
Crossref
Karim Maloum, Catherine Settegrana, Elise Chapiro, Bruno Cazin, Stéphane Leprêtre, Alain Delmer, Michel Leporrier, Brigitte Dreyfus, Olivier Tournilhac, Beatrice Mahe, Florence Nguyen-Khac, Claude Lesty, Frederic Davi & Hélène Merle-Béral. (2009) IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. Annals of Hematology 88:12, pages 1215-1221.
Crossref
Crossref
W. XU, J.-Y. LI, Q.-D. SHEN, Y.-J. WU, H. YU & L. FAN. (2009) Expression level of lipoprotein lipase in Chinese patients with chronic lymphocytic leukemia and its correlation with other prognostic factors. International Journal of Laboratory Hematology 31:5, pages 552-559.
Crossref
Crossref
Holger Nückel, Magdalena Switala, Crista H. Collins, Ludger Sellmann, Hans Grosse-Wilde, Ulrich Dührsen & Vera Rebmann. (2009) High CD49d protein and mRNA expression predicts poor outcome in chronic lymphocytic leukemia. Clinical Immunology 131:3, pages 472-480.
Crossref
Crossref
Femke Van Bockstaele, Bruno Verhasselt & Jan Philippé. (2009) Prognostic markers in chronic lymphocytic leukemia: A comprehensive review. Blood Reviews 23:1, pages 25-47.
Crossref
Crossref
J B Weinberg, A D Volkheimer, M Mihovilovic, N Jiang, Y Chen, K Bond, J O Moore, J P Gockerman, L F Diehl, C M de Castro, D A Rizzieri, M C Levesque, R DeKroon & W J Strittmatter. (2008) Apolipoprotein E genotype as a determinant of survival in chronic lymphocytic leukemia. Leukemia 22:12, pages 2184-2192.
Crossref
Crossref
Carol Moreno & Emili Montserrat. (2008) New prognostic markers in chronic lymphocytic leukemia. Blood Reviews 22:4, pages 211-219.
Crossref
Crossref
C P Pallasch, J Schwamb, S Königs, A Schulz, S Debey, D Kofler, J L Schultze, M Hallek, A Ultsch & C-M Wendtner. (2007) Targeting lipid metabolism by the lipoprotein lipase inhibitor orlistat results in apoptosis of B-cell chronic lymphocytic leukemia cells. Leukemia 22:3, pages 585-592.
Crossref
Crossref
John G. Gribben. (2008) Molecular Profiling in CLL. Hematology 2008:1, pages 444-449.
Crossref
Crossref
Thomas J. Kipps. (2007) The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia. Best Practice & Research Clinical Haematology 20:3, pages 415-424.
Crossref
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:1, pages 44-51.
Crossref
Crossref
A Hüttmann, L Klein-Hitpass, J Thomale, R Deenen, A Carpinteiro, H Nückel, P Ebeling, A Führer, J Edelmann, L Sellmann, U Dührsen & J Dürig. (2006) Gene expression signatures separate B-cell chronic lymphocytic leukaemia prognostic subgroups defined by ZAP-70 and CD38 expression status. Leukemia 20:10, pages 1774-1782.
Crossref
Crossref
Emili Montserrat. (2006) New Prognostic Markers in CLL. Hematology 2006:1, pages 279-284.
Crossref
Crossref